ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,079,000 | +145.8% | 152,795 | +29.3% | 0.32% | +183.8% |
| Q1 2019 | $2,880,000 | +65.9% | 118,145 | +14.2% | 0.11% | +109.4% |
| Q2 2018 | $1,736,000 | +6.0% | 103,465 | +3.2% | 0.05% | +1.9% |
| Q1 2018 | $1,637,000 | -39.7% | 100,300 | -54.6% | 0.05% | -39.5% |
| Q3 2017 | $2,717,000 | +14.4% | 220,907 | -22.1% | 0.09% | +34.4% |
| Q2 2017 | $2,374,000 | -35.8% | 283,667 | -31.4% | 0.06% | -39.6% |
| Q1 2017 | $3,697,000 | -21.1% | 413,530 | -22.4% | 0.11% | -15.2% |
| Q4 2016 | $4,685,000 | +42.9% | 533,000 | +9.7% | 0.12% | +37.4% |
| Q3 2016 | $3,279,000 | +66.0% | 485,780 | -12.5% | 0.09% | +56.9% |
| Q2 2016 | $1,975,000 | +6483.3% | 554,890 | +5345.4% | 0.06% | +5700.0% |
| Q1 2016 | $30,000 | -30.2% | 10,190 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $43,000 | -8.5% | 10,190 | -1.8% | 0.00% | 0.0% |
| Q3 2015 | $47,000 | -25.4% | 10,380 | -17.5% | 0.00% | -50.0% |
| Q4 2013 | $63,000 | -20.3% | 12,575 | -1.8% | 0.00% | 0.0% |
| Q3 2013 | $79,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |